• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种模拟各种疫苗和接种策略中适应性免疫反应的数学模型。

A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies.

机构信息

Department of Life Science, Dezhou University, Dezhou, 253023, China.

State Key Laboratory of Microbial Metabolism, Shanghai-Islamabad-Belgrade Joint Innovation Center on Antibacterial Resistances, Joint International Research Laboratory of Metabolic & Developmental Sciences, School of Life Sciences and Biotechnology, Shanghai Jiao Tong University, Shanghai, 200030, P. R. China.

出版信息

Sci Rep. 2024 Oct 14;14(1):23995. doi: 10.1038/s41598-024-74221-x.

DOI:10.1038/s41598-024-74221-x
PMID:39402093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11473516/
Abstract

Vaccination has been widely recognized as an effective measure for preventing infectious diseases. To facilitate quantitative research into the activation of adaptive immune responses in the human body by vaccines, it is important to develop an appropriate mathematical model, which can provide valuable guidance for vaccine development. In this study, we constructed a novel mathematical model to simulate the dynamics of antibody levels following vaccination, based on principles from immunology. Our model offers a concise and accurate representation of the kinetics of antibody response. We conducted a comparative analysis of antibody dynamics within the body after administering several common vaccines, including traditional inactivated vaccines, mRNA vaccines, and future attenuated vaccines based on defective interfering viral particles (DVG). Our findings suggest that booster shots play a crucial role in enhancing Immunoglobulin G (IgG) antibody levels, and we provide a detailed discussion on the advantages and disadvantages of different vaccine types. From a mathematical standpoint, our model proposes four essential approaches to guide vaccine design: enhancing antigenic T-cell immunogenicity, directing the production of high-affinity antibodies, reducing the rate of IgG decay, and lowering the peak level of vaccine antigen-antibody complexes. Our study contributes to the understanding of vaccine design and its application by explaining various phenomena and providing guidance in comprehending the interactions between antibodies and antigens during the immune process.

摘要

疫苗接种已被广泛认为是预防传染病的有效措施。为了便于对疫苗在人体中激活适应性免疫反应进行定量研究,开发适当的数学模型非常重要,这可为疫苗开发提供有价值的指导。在这项研究中,我们根据免疫学原理构建了一个新的数学模型来模拟接种疫苗后抗体水平的动态变化。我们的模型提供了对抗体反应动力学的简洁而准确的表示。我们对几种常见疫苗(包括传统的灭活疫苗、mRNA 疫苗和基于缺陷干扰病毒颗粒(DVG)的未来减毒疫苗)在体内的抗体动力学进行了比较分析。我们的研究结果表明,加强针在提高免疫球蛋白 G(IgG)抗体水平方面起着至关重要的作用,我们还详细讨论了不同疫苗类型的优缺点。从数学角度来看,我们的模型提出了四种指导疫苗设计的基本方法:增强抗原 T 细胞免疫原性、引导产生高亲和力抗体、降低 IgG 衰减率以及降低疫苗抗原-抗体复合物的峰值水平。我们的研究通过解释各种现象并提供对免疫过程中抗体和抗原相互作用的理解指导,为疫苗设计及其应用的理解做出了贡献。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/178b99ebc526/41598_2024_74221_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/162b6d27ef3a/41598_2024_74221_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/2fefdc244596/41598_2024_74221_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/3b40b60a7ad8/41598_2024_74221_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/a3391c1d0bb2/41598_2024_74221_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/1fc219f86143/41598_2024_74221_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/d42335efd529/41598_2024_74221_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/ca8cd755d239/41598_2024_74221_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/d986793bbcfd/41598_2024_74221_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/528172f54d24/41598_2024_74221_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/178b99ebc526/41598_2024_74221_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/162b6d27ef3a/41598_2024_74221_Figa_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/2fefdc244596/41598_2024_74221_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/3b40b60a7ad8/41598_2024_74221_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/a3391c1d0bb2/41598_2024_74221_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/1fc219f86143/41598_2024_74221_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/d42335efd529/41598_2024_74221_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/ca8cd755d239/41598_2024_74221_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/d986793bbcfd/41598_2024_74221_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/528172f54d24/41598_2024_74221_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f3dd/11473516/178b99ebc526/41598_2024_74221_Fig11_HTML.jpg

相似文献

1
A mathematical model simulating the adaptive immune response in various vaccines and vaccination strategies.一种模拟各种疫苗和接种策略中适应性免疫反应的数学模型。
Sci Rep. 2024 Oct 14;14(1):23995. doi: 10.1038/s41598-024-74221-x.
2
Immunogenicity of COVID-19 booster vaccination in IEI patients and their one year clinical follow-up after start of the COVID-19 vaccination program.新型冠状病毒肺炎疫苗接种计划启动后,免疫缺陷病(IEI)患者接种新型冠状病毒肺炎加强针的免疫原性及其一年临床随访
Front Immunol. 2024 Apr 18;15:1390022. doi: 10.3389/fimmu.2024.1390022. eCollection 2024.
3
Robust Antibody Levels in Both Diabetic and Non-Diabetic Individuals After BNT162b2 mRNA COVID-19 Vaccination.BNT162b2 mRNA新冠疫苗接种后糖尿病和非糖尿病个体均产生强劲抗体水平。
Front Immunol. 2021 Nov 24;12:752233. doi: 10.3389/fimmu.2021.752233. eCollection 2021.
4
Diversified humoral immunity and impacts of booster vaccines: SARS-CoV-2 antibody profile and Omicron BA.2 neutralization before and after first or second boosters.多元化的体液免疫和加强疫苗的影响:初次或第二次加强针前后 SARS-CoV-2 抗体特征和奥密克戎 BA.2 的中和作用。
Microbiol Spectr. 2024 Oct 3;12(10):e0060524. doi: 10.1128/spectrum.00605-24. Epub 2024 Aug 20.
5
Assessment of immune responses to H5N1 inactivated influenza vaccine among individuals previously primed with H5N2 live attenuated influenza vaccine.对先前接种过H5N2减毒活流感疫苗的个体进行H5N1灭活流感疫苗免疫反应评估。
Hum Vaccin Immunother. 2015;11(12):2839-48. doi: 10.1080/21645515.2015.1069931.
6
Modeling of anti-spike IgG and neutralizing antibody waning after anti-SARS-CoV-2 mRNA vaccination.抗 SARS-CoV-2 mRNA 疫苗接种后抗刺突 IgG 和中和抗体衰减的建模。
Vaccine. 2024 Aug 30;42(21):126146. doi: 10.1016/j.vaccine.2024.07.047. Epub 2024 Jul 20.
7
Antibody response and maternal immunity upon boosting PRRSV-immune sows with experimental farm-specific and commercial PRRSV vaccines.用实验场特异性和商业 PRRSV 疫苗对 PRRSV 免疫母猪进行加强免疫后的抗体反应和母源免疫力。
Vet Microbiol. 2013 Dec 27;167(3-4):260-71. doi: 10.1016/j.vetmic.2013.08.017. Epub 2013 Aug 28.
8
Non-cross-reactive epitopes dominate the humoral immune response to COVID-19 vaccination - kinetics of plasma antibodies, plasmablasts and memory B cells.非交叉反应表位主导 COVID-19 疫苗接种的体液免疫反应 - 血浆抗体、浆母细胞和记忆 B 细胞的动力学。
Front Immunol. 2024 May 14;15:1382911. doi: 10.3389/fimmu.2024.1382911. eCollection 2024.
9
Broadly Reactive IgG Responses to Heterologous H5 Prime-Boost Influenza Vaccination Are Shaped by Antigenic Relatedness to Priming Strains.广泛反应性 IgG 对异源 H5 疫苗加强免疫的反应受与初始株抗原相关性的影响。
mBio. 2021 Aug 31;12(4):e0044921. doi: 10.1128/mBio.00449-21. Epub 2021 Jul 6.
10
Principles of Vaccination.疫苗接种原则
Methods Mol Biol. 2016;1403:57-84. doi: 10.1007/978-1-4939-3387-7_3.

引用本文的文献

1
Multiscale information processing in the immune system.免疫系统中的多尺度信息处理
Front Immunol. 2025 Jul 21;16:1563992. doi: 10.3389/fimmu.2025.1563992. eCollection 2025.
2
A consensus mathematical model of vaccine-induced antibody dynamics for multiple vaccine platforms and pathogens.针对多种疫苗平台和病原体的疫苗诱导抗体动力学的共识数学模型。
Front Immunol. 2025 Jun 26;16:1596518. doi: 10.3389/fimmu.2025.1596518. eCollection 2025.
3
Studying Disease Reinfection Rates, Vaccine Efficacy, and the Timing of Vaccine Rollout in the Context of Infectious Diseases: A COVID-19 Case Study.

本文引用的文献

1
The Mathematical Modeling of the Host-Virus Interaction in Dengue Virus Infection: A Quantitative Study.登革病毒感染中宿主-病毒相互作用的数学建模:定量研究。
Viruses. 2024 Jan 31;16(2):216. doi: 10.3390/v16020216.
2
An agent-based model with antibody dynamics information in COVID-19 epidemic simulation.一种在新冠疫情模拟中包含抗体动力学信息的基于主体的模型。
Infect Dis Model. 2023 Nov 10;8(4):1151-1168. doi: 10.1016/j.idm.2023.11.001. eCollection 2023 Dec.
3
Antibody Dynamics Simulation-A Mathematical Exploration of Clonal Deletion and Somatic Hypermutation.
在传染病背景下研究疾病再感染率、疫苗效力及疫苗推广时机:以新冠疫情为例
Int J Environ Res Public Health. 2025 May 3;22(5):731. doi: 10.3390/ijerph22050731.
4
A Multiscale Quantitative Systems Pharmacology Model for the Development and Optimization of mRNA Vaccines.一种用于mRNA疫苗研发与优化的多尺度定量系统药理学模型。
CPT Pharmacometrics Syst Pharmacol. 2025 Jul;14(7):1213-1224. doi: 10.1002/psp4.70041. Epub 2025 May 26.
5
Analyzing Differences in Viral Dynamics Between Vaccinated and Unvaccinated RSV Patients.分析接种疫苗和未接种疫苗的呼吸道合胞病毒(RSV)患者之间的病毒动力学差异。
Epidemiologia (Basel). 2025 Apr 1;6(2):16. doi: 10.3390/epidemiologia6020016.
抗体动力学模拟——克隆缺失和体细胞超突变的数学探索
Biomedicines. 2023 Jul 20;11(7):2048. doi: 10.3390/biomedicines11072048.
4
Proteomics-based vaccine targets annotation and design of subunit and mRNA-based vaccines for Monkeypox virus (MPXV) against the recent outbreak.基于蛋白质组学的疫苗靶点注释和设计用于猴痘病毒(MPXV)的亚单位和基于 mRNA 的疫苗,以应对最近的疫情爆发。
Comput Biol Med. 2023 Jun;159:106893. doi: 10.1016/j.compbiomed.2023.106893. Epub 2023 Apr 10.
5
Generation and Functional Analysis of Defective Viral Genomes during SARS-CoV-2 Infection.在 SARS-CoV-2 感染期间,缺陷型病毒基因组的产生和功能分析。
mBio. 2023 Jun 27;14(3):e0025023. doi: 10.1128/mbio.00250-23. Epub 2023 Apr 19.
6
Mathematical modeling of plus-strand RNA virus replication to identify broad-spectrum antiviral treatment strategies.正链 RNA 病毒复制的数学建模,以确定广谱抗病毒治疗策略。
PLoS Comput Biol. 2023 Apr 4;19(4):e1010423. doi: 10.1371/journal.pcbi.1010423. eCollection 2023 Apr.
7
Tracking the COVID-19 vaccines: The global landscape.追踪 COVID-19 疫苗:全球形势。
Hum Vaccin Immunother. 2023 Dec 31;19(1):2191577. doi: 10.1080/21645515.2023.2191577. Epub 2023 Mar 30.
8
mRNA Vaccines against SARS-CoV-2: Advantages and Caveats.mRNA 疫苗对抗 SARS-CoV-2:优势与注意事项。
Int J Mol Sci. 2023 Mar 21;24(6):5944. doi: 10.3390/ijms24065944.
9
Endemic, epidemic and pandemic infections: the roles of natural and acquired herd immunity.地方性、流行性和大流行性感染:自然和后天群体免疫的作用。
Curr Opin Infect Dis. 2023 Jun 1;36(3):171-176. doi: 10.1097/QCO.0000000000000916. Epub 2023 Mar 20.
10
A Novel Mathematical Model That Predicts the Protection Time of SARS-CoV-2 Antibodies.一种预测 SARS-CoV-2 抗体保护时间的新数学模型。
Viruses. 2023 Feb 20;15(2):586. doi: 10.3390/v15020586.